U.S. pharma giant Pfizer's COVID-19 pill to be manufactured in 95 countries

U.S. pharma giant Pfizer has signed a license-sharing deal one that will allow its experimental COVID-19 pill to be manufactured in 95 countries. This means that the pill will be easily available to more than half of the globe.